Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
Business
Taking Ozempic and worried about vision loss? This test can help you understand your risk.
Related
Business
Morgan Stanley’s Mike Wilson says an S&P 500 correction may be exactly what the market needs
The chief U.S. equity strategist at the investment bank favors large-capitalization quality companies.
Business
Two stock picks from a money manager who expects small caps to roar in 2027
Calamos Investments manager Brandon Nelson’s four-star fund is betting on financial services apps.
Business
Blockchain.com targets $500 million IPO at up to $6 billion valuation
The London-based crypto services company confidentially filed for an initial public offering with the Securities and Exchange Commission earlier this year.
Business
Novo Nordisk strikes second licensing deal since frosty capital-markets day
Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.